Chinese healthcare firms to raise $2 billion in HK IPOs

China NT Pharma and Shanghai Pharmaceuticals aim to raise as much as $2 billion in Hong Kong IPOs this month.
They might hurt, but the increasing popularity of vaccines in China is good news for NT Pharma
They might hurt, but the increasing popularity of vaccines in China is good news for NT Pharma

Hong Kong investors are preparing for an influx of healthcare equities that could absorb $2 billion of capital in the coming weeks as two Chinese pharmaceutical companies roll out plans for initial public offerings.

¬ Haymarket Media Limited. All rights reserved.

Sign In to Your Account To Access Exclusive FinanceAsia Content!

Please sign in to your subscription to unlock full access to our premium FA resources.

Free Registration & 7-Day Trial
Register now to enjoy a 7-day free trial - no registration fees required. Click the link to get started.

Note: This free trial is a one-time offer.

Questions?
If you have any enquiries or would like a quote for a team or company licence, please contact us at [email protected]. Our subscription team will be happy to assist you.

Share our publication on social media
Share our publication on social media